Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3110)
All Articles published online
|
Publishing Process of This Article
|
Jul 24, 2024 (publication date) through Sep 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cai Z, Gao L, Hu K, Wang QM. Parthenolide enhances the metronomic chemotherapy effect of cyclophosphamide in lung cancer by inhibiting the NF-kB signaling pathway. World J Clin Oncol 2024; 15(7): 895-907 [PMID: 39071467 DOI: 10.5306/wjco.v15.i7.895] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v15/i7/895.htm |
| Number | Citing Articles |
| 1 |
Chi Teng, Jia-Wen Chen, Li-Sha Shen, Sibao Chen, Guo-Qing Chen. Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways. Cancer Drug Resistance 2025; doi: 10.20517/cdr.2024.178
|
| 2 |
Zhai Pingping, Chen Nan, Tang Yong. Phytochemicals and their Nanoformulations for Overcoming Drug Resistance in Head and Neck Squamous Cell Carcinoma. Pharmaceutical Research 2025; 42(3): 429 doi: 10.1007/s11095-025-03836-0
|
| 3 |
Özge Kandemir, Elif Dalkılınç. Protective Potential of Morin in Ifosfamide-Induced Lung Toxicity: Modulation of Oxidative Stress, Inflammation and Apoptosis Parameters. Veterinary Sciences and Practices 2025; 20(1): 50 doi: 10.17094/vetsci.1659052
|
| 4 |
Feifei Li, Qin Qi, Yu Qiao, Yan Huang, Yuan Lu, Kan Gu, Huirong Liu, Chunfang Gao, Sheng Liu, Huangan Wu. Curcumenol inhibits malignant progression and promotes ferroptosis via the SLC7A11/NF‑κB/TGF‑β pathway in triple‑negative breast cancer. International Journal of Molecular Medicine 2025; 56(1): 1 doi: 10.3892/ijmm.2025.5552
|
| 5 |
Salma A. El-Marasy, Hadir Farouk, Marwa S. Khattab, Marwan Abdelbaset. Protective effect of roflumilast on cyclophosphamide-induced ovarian toxicity in rats: role of SIRT1/Nrf2/nF-ĸB pathway. Immunopharmacology and Immunotoxicology 2025; 47(3): 354 doi: 10.1080/08923973.2025.2482804
|
| 6 |
Jian Li, Xin Li, Hongwei Liu. Sesquiterpene lactones and cancer: new insight into antitumor and anti-inflammatory effects of parthenolide-derived Dimethylaminomicheliolide and Micheliolide. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1551115
|
| 7 |
Xiaoyan Duan, Xiaoyu Fan, Haiyan Jiang, Jie Li, Xue Shen, Zeao Xu, Ziqi Zhou, Jia Xu, Chongze Chen, Hongtao Jin. Herb-drug interactions in oncology: pharmacodynamic/pharmacokinetic mechanisms and risk prediction. Chinese Medicine 2025; 20(1) doi: 10.1186/s13020-025-01156-4
|
| 8 |
Reza Shahhoseini. Metabolite distribution, relationships of phytochemical compositions and anticancer compound tracking in organs of Tanacetum parthenium L. as a sustainable pharmaceutical manufacturing plant. Environmental Technology & Innovation 2025; 38: 104063 doi: 10.1016/j.eti.2025.104063
|
| 9 |
Jiye Liu, Yu Liu, Jiachun Li, Shuang Shen. Effects of parthenolide on amino acid metabolism and oxidative stress in lung adenocarcinoma based on quantitative proteomic analysis, targeted amino acid metabolomics, network pharmacology, and experimental validation. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1642866
|